Emerging Fungi

Infectious Disease Clinics of North America

Volumn 20, Issue 3, 2006, Pages 563-579

  Nucci, Marcio ^a   Anaissie, Elias ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CULTURE; CLINICAL FEATURE; FUNGEMIA; FUSARIUM; HUMAN; IMMUNE DEFICIENCY; LABORATORY DIAGNOSIS; LUNG MYCOSIS; MYCOSIS; PATHOGENESIS; PROGNOSIS; RARE DISEASE; REVIEW; SINUSITIS; SKIN INFECTION;

COMMUNICABLE DISEASES, EMERGING; FUSARIUM; HUMANS; MYCOSES;

EID: 33748696839     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2006.06.002     Document Type: Review

References (96)

1. Pappas P.G., Rex J.H., Lee J., et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37 5 (2003) 634-643
2. Marr K.A., Carter R.A., Crippa F., et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34 7 (2002) 909-917
3. Kauffman C.A. Zygomycosis: reemergence of an old pathogen. Clin Infect Dis 39 4 (2004) 588-590
4. Nucci M., Marr K.A., Queiroz-Telles F., et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 38 9 (2004) 1237-1242
5. Revankar S.G., Patterson J.E., Sutton D.A., et al. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 34 4 (2002) 467-476
6. Procop G.W., and Roberts G.D. Emerging fungal diseases: the importance of the host. Clin Lab Med 24 (2004) 691-719
7. Elvers K.T., Leeming K., Moore C.P., et al. Bacterial-fungal biofilms in flowing water photo-processing tanks. J Appl Microbiol 84 4 (1998) 607-618
8. Nelson P.E., Dignani M.C., and Anaissie E.J. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 7 4 (1994) 479-504
9. Hayden R.T., Isotalo P.A., Parrett T., et al. In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol 12 1 (2003) 21-26
10. Issakainen J., Jalava J., Eerola E., et al. Relatedness of Pseudallescheria, Scedosporium and Graphium pro parte based on SSU rDNA sequences. J Med Vet Mycol 35 6 (1997) 389-398
11. Walsh T.J., Groll A., Hiemenz J., et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 10 Suppl 1 (2004) 48-66
12. Nucci M., and Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 35 8 (2002) 909-920
13. Doczi I., Gyetvai T., Kredics L., et al. Involvement of Fusarium spp. in fungal keratitis. Clin Microbiol Infect 10 9 (2004) 773-776
14. Rippon J.W., Larson R.A., Rosenthal D.M., et al. Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species: three cases and review of the literature. Mycopathologia 101 2 (1988) 105-111
15. Kerr C.M., Perfect J.R., Craven P.C., et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med 99 3 (1983) 334-336
16. Flynn J.T., Meislich D., Kaiser B.A., et al. Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature. Perit Dial Int 16 1 (1996) 52-57
17. Velasco E., Martins C.A., and Nucci M. Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur J Clin Microbiol Infect Dis 14 8 (1995) 697-699
18. Raad I., and Hachem R. Treatment of central venous catheter-related fungemia due to Fusarium oxysporum. Clin Infect Dis 20 3 (1995) 709-711
19. Ammari L.K., Puck J.M., and McGowan K.L. Catheter-related Fusarium solani fungemia and pulmonary infection in a patient with leukemia in remission. Clin Infect Dis 16 1 (1993) 148-150
20. Madhavan M., Ratnakar C., Veliath A.J., et al. Primary disseminated fusarial infection. Postgrad Med J 68 796 (1992) 143-144
21. Sander A., Beyer U., and Amberg R. Systemic Fusarium oxysporum infection in an immunocompetent patient with an adult respiratory distress syndrome (ARDS) and extracorporeal membrane oxygenation (ECMO). Mycoses 41 3-4 (1998) 109-111
22. Jakle C., Leek J.C., Olson D.A., et al. Septic arthritis due to Fusarium solani. J Rheumatol 10 1 (1983) 151-153
23. Kurien M., Anandi V., Raman R., et al. Maxillary sinus fusariosis in immunocompetent hosts. J Laryngol Otol 106 8 (1992) 733-736
24. Murray C.K., Beckius M.L., and McAllister K. Fusarium proliferatum superficial suppurative thrombophlebitis. Mil Med 168 5 (2003) 426-427
25. Sturm A.W., Grave W., and Kwee W.S. Disseminated Fusarium oxysporum infection in patient with heatstroke. Lancet 1 8644 (1989) 968
26. Pflugfelder S.C., Flynn Jr. H.W., Zwickey T.A., et al. Exogenous fungal endophthalmitis. Ophthalmology 95 1 (1988) 19-30
27. Gabriele P., and Hutchins R.K. Fusarium endophthalmitis in an intravenous drug abuser. Am J Ophthalmol 122 1 (1996) 119-121
28. Bourguignon R.L., Walsh A.F., Flynn J.C., et al. Fusarium species osteomyelitis. Case report. J Bone Joint Surg [Am] 58 5 (1976) 722-723
29. Nucci M., Anaissie E.J., Queiroz-Telles F., et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 98 2 (2003) 315-319
30. Anaissie E.J., Kuchar R.T., Rex J.H., et al. Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis 33 11 (2001) 1871-1878
31. Girmenia C., Arcese W., Micozzi A., et al. Onychomycosis as a possible origin of disseminated Fusarium solani infection in a patient with severe aplastic anemia. Clin Infect Dis 14 5 (1992) 1167
32. Tanure M.A., Cohen E.J., Sudesh S., et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 19 3 (2000) 307-312
33. Rosa Jr. R.H., Miller D., and Alfonso E.C. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 101 6 (1994) 1005-1013
34. Dursun D., Fernandez V., Miller D., et al. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea 22 4 (2003) 300-303
35. Ferrer C., Alio J., Rodriguez A., et al. Endophthalmitis caused by Fusarium proliferatum. J Clin Microbiol 43 10 (2005) 5372-5375
36. Rezai K.A., Eliott D., Plous O., et al. Disseminated Fusarium infection presenting as bilateral endogenous endophthalmitis in a patient with acute myeloid leukemia. Arch Ophthalmol 123 5 (2005) 702-703
37. Tiribelli M., Zaja F., Fili C., et al. Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia. Eur J Haematol 68 5 (2002) 314-317
38. Wickern G.M. Fusarium allergic fungal sinusitis. J Allergy Clin Immunol 92 4 (1993) 624-625
39. Stammberger H. Endoscopic surgery for mycotic and chronic recurring sinusitis. Ann Otol Rhinol Laryngol Suppl 119 (1985) 1-11
40. Valenstein P., and Schell W.A. Primary intranasal Fusarium infection. Potential for confusion with rhinocerebral zygomycosis. Arch Pathol Lab Med 110 8 (1986) 751-754
41. Segal B.H., Walsh T.J., Liu J.M., et al. Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia. J Clin Microbiol 36 6 (1998) 1772-1776
42. Lopes J.O., de Mello E.S., and Klock C. Mixed intranasal infection caused by Fusarium solani and a zygomycete in a leukaemic patient. Mycoses 38 7-8 (1995) 281-284
43. Anaissie E., Kantarjian H., Ro J., et al. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) 67 2 (1988) 77-83
44. Nakar C., Livny G., Levy I., et al. Mycetoma of the renal pelvis caused by Fusarium species. Pediatr Infect Dis J 20 12 (2001) 1182-1183
45. Pereiro Jr. M., Abalde M.T., Zulaica A., et al. Chronic infection due to Fusarium oxysporum mimicking lupus vulgaris: case report and review of cutaneous involvement in fusariosis. Acta Derm Venereol 81 1 (2001) 51-53
46. Sridhar H., Subramanyam J.R., Appaji L., et al. Fusarium solani fungemia in a patient with acute lymphoblastic leukemia. Indian J Cancer 38 1 (2001) 19-21
47. Letscher-Bru V., Campos F., Waller J., et al. Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient. J Clin Microbiol 40 3 (2002) 1100-1102
48. Pushker N., Chra M., Bajaj M.S., et al. Necrotizing periorbital Fusarium infection-an emerging pathogen in immunocompetent individuals. J Infect 44 4 (2002) 236-239
49. Tomimori-Yamashita J., Ogawa M.M., Hirata S.H., et al. Mycetoma caused by Fusarium solani with osteolytic lesions on the hand: case report. Mycopathologia 153 1 (2002) 11-14
50. Apostolidis J., Bouzani M., Platsouka E., et al. Resolution of fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin. Clin Infect Dis 36 10 (2003) 1349-1350
51. Bader M., Jafri A.K., Krueger T., et al. Fusarium osteomyelitis of the foot in a patient with diabetes mellitus. Scand J Infect Dis 35 11-12 (2003) 895-896
52. Cocuroccia B., Gaido J., Gubinelli E., et al. Localized cutaneous hyalohyphomycosis caused by a Fusarium species infection in a renal transplant patient. J Clin Microbiol 41 2 (2003) 905-907
53. Consigny S., Dhedin N., Datry A., et al. Successful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin Infect Dis 37 2 (2003) 311-313
54. Durand-Joly I., Alfandari S., Benchikh Z., et al. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia. J Clin Microbiol 41 10 (2003) 4898-4900
55. Mansoory D., Roozbahany N.A., Mazinany H., et al. Chronic Fusarium infection in an adult patient with undiagnosed chronic granulomatous disease. Clin Infect Dis 37 7 (2003) e107-e108
56. Rodriguez C.A., Lujan-Zilbermann J., Woodard P., et al. Successful treatment of disseminated fusariosis. Bone Marrow Transplant 31 5 (2003) 411-412
57. Vincent A.L., Cabrero J.E., Greene J.N., et al. Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient. Cancer Control 10 5 (2003) 414-419
58. Yera H., Bougnoux M.E., Jeanrot C., et al. Mycetoma of the foot caused by Fusarium solani: identification of the etiologic agent by DNA sequencing. J Clin Microbiol 41 4 (2003) 1805-1808
59. Bigley V.H., Duarte R.F., Gosling R.D., et al. Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole. Bone Marrow Transplant 34 9 (2004) 815-817
60. Guimera-Martin-Neda F., Garcia-Bustinduy M., Noda-Cabrera A., et al. Cutaneous infection by Fusarium: successful treatment with oral voriconazole. Br J Dermatol 150 4 (2004) 777-778
61. Guzman-Cottrill J.A., Zheng X., and Chadwick E.G. Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 23 11 (2004) 1059-1061
62. Hamaki T., Kami M., Kishi A., et al. Vesicles as initial skin manifestation of disseminated fusariosis after non-myeloablative stem cell transplantation. Leuk Lymphoma 45 3 (2004) 631-633
63. Herbrecht R., Kessler R., Kravanja C., et al. Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. J Heart Lung Transplant 23 12 (2004) 1451-1454
64. Kivivuori S.M., Hovi L., Vettenranta K., et al. Invasive fusariosis in two transplanted children. Eur J Pediatr 163 11 (2004) 692-693
65. Moschovi M., Trimis G., Anastasopoulos J., et al. Subacute vertebral osteomyelitis in a child with diabetes mellitus associated with Fusarium. Pediatr Int 46 6 (2004) 740-742
66. Rothe A., Seibold M., Hoppe T., et al. Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol 83 6 (2004) 394-397
67. Anandi V., Vishwanathan P., Sasikala S., et al. Fusarium solani breast abscess. Indian J Med Microbiol 23 3 (2005) 198-199
68. Dornbusch H.J., Buzina W., Summerbell R.C., et al. Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain. J Clin Microbiol 43 4 (2005) 1998-2001
69. Garbino J., Uckay I., Rohner P., et al. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Int 18 5 (2005) 613-618
70. Gardner J.M., Nelson M.M., and Heffernan M.P. Chronic cutaneous fusariosis. Arch Dermatol 141 6 (2005) 794-795
71. Sierra-Hoffman M., Paltiyevich-Gibson S., Carpenter J.L., et al. Fusarium osteomyelitis: case report and review of the literature. Scand J Infect Dis 37 3 (2005) 237-240
72. Backman K.S., Roberts M., and Patterson R. Allergic bronchopulmonary mycosis caused by Fusarium vasinfectum. Am J Respir Crit Care Med 152 4 Pt 1 (1995) 1379-1381
73. Castagnola E., Garaventa A., Conte M., et al. Survival after fungemia due to Fusarium moniliforme in a child with neuroblastoma. Eur J Clin Microbiol Infect Dis 12 4 (1993) 308-309
74. Eljaschewitsch J., Sandfort J., Tintelnot K., et al. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B. Mycoses 39 3-4 (1996) 115-119
75. Kiehn T.E., Nelson P.E., Bernard E.M., et al. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. J Clin Microbiol 21 4 (1985) 501-504
76. Musa M.O., Al Eisa A., Halim M., et al. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol 108 3 (2000) 544-548
77. Perfect J.R. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 40 Suppl 6 (2005) S401-S408
78. Perfect J.R., Marr K.A., Walsh T.J., et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 36 9 (2003) 1122-1131
79. Raad I, Chapman S, Bradsher R, et al. Posaconazole salvage therapy for invasive fungal infections [abstract M-669]. In: Programs and abstracts of the 40th Interscience Symposium on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 2004.
80. Cuenca-Estrella M., Gomez-Lopez A., Mellado E., et al. In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi. Antimicrob Agents Chemother 49 12 (2005) 5136-5138
81. Pfaller M.A., and Diekema D.J. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42 10 (2004) 4419-4431
82. Zaas A.K., and Alexander B.D. Echinocandins: role in antifungal therapy, 2005. Expert Opin Pharmacother 6 10 (2005) 1657-1668
83. Lupinetti F.M., Giller R.H., and Trigg M.E. Operative treatment of Fusarium fungal infection of the lung. Ann Thorac Surg 49 6 (1990) 991-992
84. Anaissie E.J., Stratton S.L., Dignani M.C., et al. Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin Infect Dis 35 8 (2002) E86-E88
85. Dignani M.C., Anaissie E.J., Hester J.P., et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 11 10 (1997) 1621-1630
86. Hennequin C., Benkerrou M., Gaillard J.L., et al. Role of granulocyte colony-stimulating factor in the management of infection with Fusarium oxysporum in a neutropenic child. Clin Infect Dis 18 3 (1994) 490-491
87. Bouza E., and Munoz P. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin Microbiol Infect 10 Suppl 1 (2004) 76-85
88. Castiglioni B., Sutton D.A., Rinaldi M.G., et al. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 81 5 (2002) 333-348
89. Berenguer J., Rodriguez-Tudela J.L., Richard C., et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group. Medicine (Baltimore) 76 4 (1997) 256-265
90. Maertens J., Lagrou K., Deweerdt H., et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review. Ann Hematol 79 6 (2000) 340-344
91. Fleming R.V., Walsh T.J., and Anaissie E.J. Emerging and less common fungal pathogens. Infect Dis Clin North Am 16 4 (2002) 915-933
92. Walsh T.J., Lutsar I., Driscoll T., et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21 3 (2002) 240-248
93. Guarro J., Gams W., Pujol I., et al. Acremonium species: new emerging fungal opportunists-in vitro antifungal susceptibilities and review. Clin Infect Dis 25 5 (1997) 1222-1229
94. Mattei D., Mordini N., Lo N.C., et al. Successful treatment of Acremonium fungemia with voriconazole. Mycoses 46 11-12 (2003) 511-514
95. Gutierrez-Rodero F, Moragon M, Ortiz de lT, V, et al. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review. Eur J Clin Microbiol Infect Dis 1999;18(11):814-8.
96. Garbino J., Ondrusova A., Baglivo E., et al. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 34 9 (2002) 701-703